188 material Form 8-K filings that 175 companies we cover made with the SEC in April 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
First Financial Bankshares reported first-quarter 2024 net income of $53.40 million, up from $52.57 million a year earlier, with earnings per share flat at $0.37. Net interest income rose to $100.24 million, while noninterest expense increased to $63.94 million from $57.26 million, which the release attributes mainly to salary and employee benefit costs.
Net income was $53.40 million for Q1 2024 versus $52.57 million for Q1 2023; basic and diluted EPS were $0.37 in both periods.
Net interest income rose to $100.24 million from $96.29 million a year earlier; net interest margin was 3.34 percent in both periods.
Provision for credit losses was $808 thousand, down from $2.78 million in Q1 2023.
Noninterest expense rose to $63.94 million from $57.26 million, with salary, commissions and employee benefit costs up to $36.68 million from $31.46 million.
OFG Bancorp reported first-quarter 2024 results for the period ended March 31, 2024. Diluted earnings per share were $1.05, up from $0.98 in the fourth quarter of 2023 and $0.96 in the first quarter of 2023, while total core revenues were $174.2 million, down from $175.6 million sequentially but up from $164.4 million a year earlier. The results show higher earnings per share year over year, although sequential revenue and pre-provision net revenues declined.
Diluted EPS was $1.05 versus $0.98 in 4Q23 and $0.96 in 1Q23.
Total core revenues were $174.2 million, compared with $175.6 million in 4Q23 and $164.4 million in 1Q23.
Pre-provision net revenues were $83.0 million, compared with $88.2 million in 4Q23 and $74.6 million in 1Q23.
Net charge-offs were $19.8 million, compared with $16.3 million in 4Q23 and $10.1 million in 1Q23.
Badger Meter reported first quarter 2024 results for the period ended March 31, 2024, with net sales up 23% year-over-year to $196.3 million and diluted earnings per share up 50% to $0.99. Operating profit rose 46%, and the company said operating margin reached 18.6%, and it did not provide numeric guidance in the release.
Net sales of $196.3 million compared with $159.1 million a year earlier.
Diluted EPS of $0.99 compared with $0.66 in the prior year quarter.
Operating margin of 18.6%, up 290 basis points from 15.7%; utility water sales rose 29%, while flow instrumentation sales fell 3%.
Telog/Unity remote network monitoring acquisition completed at the start of 2024; the company will hold a conference call on April 18, 2024.
Blackstone reported first-quarter 2024 GAAP net income attributable to Blackstone Inc. of $847 million, compared with $85.8 million a year earlier, on total revenues of $3.69 billion versus $1.38 billion. Fee Related Earnings rose 12% to $1.2 billion, and Distributable Earnings were $1.3 billion, up 1%, with a $0.83 quarterly dividend declared. The higher GAAP results were largely driven by performance allocations and principal investment revenue, which can vary widely from quarter to quarter.
GAAP net income attributable to Blackstone Inc. was $847 million, or $1.11 diluted per share, versus $85.8 million, or $0.11 diluted per share, in the first quarter of 2023
Fee Related Earnings were $1.2 billion ($0.95 per share), up 12% from the prior-year quarter
Distributable Earnings were $1.3 billion ($0.98 per share), up 1%; total AUM reached $1,061.3 billion, up 7%
Quarterly dividend of $0.83 per share: record date April 29, 2024, payable May 6, 2024
Snap-on reported first-quarter 2024 results on April 18, 2024. Diluted EPS rose to $4.91 from $4.60, including a $0.16 benefit from a legal payment, while net sales were flat at $1,182.3 million and organic sales fell 0.8%. Operating margin before financial services improved to 22.9% from 22.0%, and the company projected 2024 capital expenditures of $100 million to $110 million and a full-year effective tax rate of 22% to 23%.
Diluted EPS of $4.91 vs. $4.60 a year earlier, including an $0.16 per share after-tax legal payment benefit
Net sales of $1,182.3 million, down $0.7 million (0.1%); organic sales down $9.9 million (0.8%)
Operating earnings before financial services of $270.9 million vs. $259.8 million; margin 22.9% vs. 22.0%
2024 capital expenditure outlook of $100 million to $110 million; full-year effective tax rate expected at 22% to 23%
Elevance Health reported first quarter 2024 results on April 18, 2024, with operating revenue of $42.3 billion, up 0.9% from a year earlier, and diluted EPS of $9.59, up 15.5%. The company raised its full-year 2024 guidance to diluted EPS greater than $34.05 and adjusted diluted EPS greater than $37.20, which signals stronger expected earnings for shareholders.
Q1 2024 diluted EPS was $9.59, up 15.5%; adjusted diluted EPS was $10.64, up 12.5%
Operating revenue was $42.3 billion, up 0.9%; total operating margin was 7.1%, up 30 basis points
Full-year 2024 diluted EPS guidance raised to greater than $34.05; adjusted diluted EPS guidance raised to greater than $37.20
Repurchased 1.1 million shares for $566 million in Q1; quarterly dividend of $1.63 per share declared, payable June 25, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.